Smooth muscle cell targeting gene delivery using artery wall binding peptide linked high mobility group box 1 A
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이민형 | - |
dc.date.accessioned | 2021-08-03T22:33:02Z | - |
dc.date.available | 2021-08-03T22:33:02Z | - |
dc.date.created | 2021-06-30 | - |
dc.date.issued | 2008-11-28 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/62683 | - |
dc.description.abstract | High mobility group box 1(HMGB1) are able to condense with plasmid DNA. Previously we generated a truncated HMGB1 derivative which lacks the acidic C-tail, reported to decrease the affinity of HMG proteins for DNA, and HMG box B. HIV-TAT protein was conjugated to truncated formation of HMGB1(HMGB1A) to enhance transfection efficiency. Apolipoprotein B-100 contains artery wall binding domain. In this study, artery wall binding peptide (ABP) was conjugated to TAT-HMGB1A for artery wall targeting and it enhance gene expression. Recombinant his tag fusion protein, TAT-HMG1A-ABP were cloned and purified. The complexes formation between TAT-HMGB1A-ABP and plasmid DNA was confirmed by gel retardation assay. pCMV-Luc and peptide complexes were added to A7R5 smooth muscle. The highest transfection efficiency of TAT-HMGB1A-ABP was at a 20/1 weight ratio. TAT-HMGB1A-ABP/pDNA complex had higher efficiency than PLL. In competition assay with free ABP, the transfection of TAT-HMGB1A-ABP was decreased by the addition of free ABP at a concentration of 300 ug/ml. MTT assay was performed to investigate whether protein carrier is non-toxic. The Recombinant protein for artery wall targeting has considerable potential to facilitate DNA delivery to smooth muscle cells. | - |
dc.publisher | 한국유전자치료학회 | - |
dc.title | Smooth muscle cell targeting gene delivery using artery wall binding peptide linked high mobility group box 1 A | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | 이민형 | - |
dc.identifier.bibliographicCitation | 한국유전자치료학회 2차 연례학술대회 | - |
dc.relation.isPartOf | 한국유전자치료학회 2차 연례학술대회 | - |
dc.citation.title | 한국유전자치료학회 2차 연례학술대회 | - |
dc.citation.conferencePlace | 서울대학교 병원 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 2 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.